Sherbrooke Park Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,941
Closed -$224K – 770
2024
Q3
$224K Buy
+5,941
New +$229K 0.05% 709
2024
Q2
– Sell
-11,464
Closed -$385K – 901
2024
Q1
$385K Buy
+11,464
New +$385K 0.08% 463

Other funds holding ATEX

Sherbrooke Park Advisers's ATEX Position: Q4 2024 in Review

Sherbrooke Park Advisers sold out of Anterix (ATEX) in Q4 2024, closing a stake of 5,941 shares — an estimated $224K sold.

Sherbrooke Park Advisers first reported a position in ATEX in Q1 2024 and held it in 2 quarters. The position peaked at $385K in Q1 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Sherbrooke Park Advisers reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 5,941 Anterix shares in Q4 2024, an estimated $224K.
  • Sherbrooke Park Advisers first reported a position in Anterix in Q1 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Anterix position peaked at $385K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.